Australia's most trusted
source of pharma news
Saturday, 18 May 2024
Posted 30 April 2024 PM
BMS is bracing for yet another shortage of Orencia subcutaneous presentations from early to mid-June due to global supply chain issues.
The disease-modifying anti-rheumatic drug is used to treat certain types of arthritis and is listed on the PBS for severe active rheumatoid arthritis.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.